MedPath

RIVA-OXAZEPAM

RIVA-OXAZEPAM

Approved
DIN Number

00568406

Drug Class

Human

Market Date

Dec 31, 1983

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00568406
AIG Number0102420002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA04 OXAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXAZEPAMActive
Strength: 15 MG
Monograph: OXAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.